Butyrate producers, “The Sentinel of Gut”: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics

Abstract

Gut-microbial butyrate is a short-chain fatty acid (SCFA) of significant physiological importance than the other major SCFAs (acetate and propionate). Most butyrate producers belong to the Clostridium cluster of the phylum Firmicutes, such as Faecalibacterium , Roseburia , Eubacterium , Anaerostipes , Coprococcus , Subdoligranulum , and Anaerobutyricum . They metabolize carbohydrates via the butyryl-CoA: acetate CoA-transferase pathway and butyrate kinase terminal enzymes to produce most of butyrate. Although, in minor fractions, amino acids can also be utilized to generate butyrate via glutamate and lysine pathways. Butyrogenic microbes play a vital role in various gut-associated metabolisms. Butyrate is used by colonocytes to generate energy, stabilizes hypoxia-inducible factor to maintain the anaerobic environment in the gut, maintains gut barrier integrity by regulating Claudin-1 and synaptopodin expression, limits pro-inflammatory cytokines (IL-6, IL-12), and inhibits oncogenic pathways (Akt/ERK, Wnt, and TGF-β signaling). Colonic butyrate producers shape the gut microbial community by secreting various anti-microbial substances, such as cathelicidins, reuterin, and β-defensin-1, and maintain gut homeostasis by releasing anti-inflammatory molecules, such as IgA, vitamin B, and microbial anti-inflammatory molecules. Additionally, butyrate producers, such as Roseburia , produce anti-carcinogenic metabolites, such as shikimic acid and a precursor of conjugated linoleic acid. In this review, we summarized the significance of butyrate, critically examined the role and relevance of butyrate producers, and contextualized their importance as microbial therapeutics.

References 173

1. 1.
   The Ability of AhR Ligands to Attenuate Delayed Type Hypersensitivity Reaction Is Associated With Alterations in the Gut Microbiota · 2021

   Not checked
2. 2.

   Abrahamsson T. Jakobsson H. Andersson A. F. Björkstén B. Engstrand L. Jenmalm M. (2014 ). Low gut microbiota diversity in early infancy precedes asthma at school age. Clin. Exp. Allergy 44, 842–850. doi:, PMID:

   Not in our library10.1111/cea.12253 (opens in a new tab)

3. 3.

   Ahlawat S. Asha S. K. K. (2021 ). Gut–organ axis: a microbial outreach and networking. Lett. Appl. Microbiol. 72, 636–668. doi:, PMID:

   Not in our library10.1111/lam.13333 (opens in a new tab)

4. 4.

   Akitsu A. Iwakura Y. (2018 ). Interleukin-17-producing γδ T (γδ17) cells in inflammatory diseases. Immunology 155, 418–426. doi:, PMID:

   Not in our library10.1111/imm.12993 (opens in a new tab)

5. 5.

   Alessi A. M. Gray V. Farquharson F. M. Flores-López A. Shaw S. Stead D.. (2020 ). β-Glucan is a major growth substrate for human gut bacteria related to Coprococcus eutactus. Environ. Microbiol. 22, 2150–2164. doi:, PMID:

   Not in our library10.1111/1462-2920.14977 (opens in a new tab)

6. 6.

   Allen-Vercoe E. Daigneault M. White A. Panaccione R. Duncan S. H. Flint H. J.. (2012 ). Anaerostipes hadrus comb. nov., a dominant species within the human colonic microbiota; reclassification of Eubacterium hadrum Moore et al. Anaerobe 18, 523–529. doi:, PMID:

   Not in our library10.1016/j.anaerobe.2012.09.002 (opens in a new tab)

7. 7.

   Altemani F. Barrett H. L. Gomez-Arango L. Josh P. David McIntyre H. Callaway L. K.. (2021 ). Pregnant women who develop preeclampsia have lower abundance of the butyrate-producer Coprococcus in their gut microbiota. Pregnancy Hypertens. 23, 211–219. doi:, PMID:

   Not in our library10.1016/j.preghy.2021.01.002 (opens in a new tab)

8. 8.

   Alves-Santos A. M. Sugizaki C. S. A. Lima G. C. Naves M. M. V. (2020 ). Prebiotic effect of dietary polyphenols: a systematic review. J. Funct. Foods 74:104169

   Not in our library10.1016/j.jff.2020.104169 (opens in a new tab)

9. 9.

   Anderson C. J. Kendall M. M. (2017 ). Salmonella enterica serovar Typhimurium strategies for host adaptation. Front. Microbiol. 8:1983. doi:, PMID:

   Not in our library10.3389/fmicb.2017.01983 (opens in a new tab)

10. 10.

    Antharam V. C. Li E. C. Ishmael A. Sharma A. Mai V. Rand K. H.. (2013 ). Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J. Clin. Microbiol. 51, 2884–2892. doi:, PMID:

    Not in our library10.1128/jcm.00845-13 (opens in a new tab)

11. 11.

    Appert O. Garcia A. R. Frei R. Roduit C. Constancias F. Neuzil-Bunesova V.. (2020 ). Initial butyrate producers during infant gut microbiota development are endospore formers. Environ. Microbiol. 22, 3909–3921. doi:, PMID:

    Not in our library10.1111/1462-2920.15167 (opens in a new tab)

12. 12.

    Bang S.-J. Kim G. Lim M. Y. Song E.-J. Jung D.-H. Kum J.-S.. (2018 ). The influence of in vitro pectin fermentation on the human fecal microbiome. AMB Express 8:98

    Not in our library10.1186/s13568-018-0629-9 (opens in a new tab)

13. 13.
    Microbial Metabolic Networks at the Mucus Layer Lead to Diet-Independent Butyrate and Vitamin B 12 Production by Intestinal Symbionts · 2017

    No notice
14. 14.

    Bisgaard H. Li N. Bonnelykke K. Chawes B. L. K. Skov T. Paludan-Müller G.. (2011 ). Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J. Allergy Clin. Immunol. 128:e5, 646–652.e5

    Not in our library10.1016/j.jaci.2011.04.060 (opens in a new tab)

15. 15.
    Butyrate Producers as Potential Next-Generation Probiotics: Safety Assessment of the Administration of Butyricicoccus pullicaecorum to Healthy Volunteers · 2018

    No notice
16. 16.

    Bothe M. K. Maathuis A. J. H. Bellmann S. Van der Vossen J. M. B. M. Berressem D. Koehler A.. (2017 ). Dose-dependent prebiotic effect of lactulose in a computer-controlled in vitro model of the human large intestine. Nutrients 9:767. doi:, PMID:

    Not in our library10.3390/nu9070767 (opens in a new tab)

17. 17.

    Braune A. Gütschow M. Engst W. Blaut M. (2001 ). Degradation of quercetin and luteolin by Eubacterium ramulus. Appl. Environ. Microbiol. 67, 5558–5567. doi:, PMID:

    Not in our library10.1128/aem.67.12.5558-5567.2001 (opens in a new tab)

18. 18.
    Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal · 2015

    No notice
19. 19.
    Mutual Metabolic Interactions in Co-cultures of the Intestinal Anaerostipes rhamnosivorans With an Acetogen, Methanogen, or Pectin-Degrader Affecting Butyrate Production · 2019

    Not checked
20. 20.

    Bultman S. J. (2016 ). The microbiome and its potential as a cancer preventive intervention. Seminars Oncol. 43, 97–106. doi:, PMID:

    Not in our library10.1053/j.seminoncol.2015.09.001 (opens in a new tab)

21. 21.

    Bultman S. J. Jobin C. (2014 ). Microbial-derived butyrate: an oncometabolite or tumor-suppressive metabolite? Cell Host Microbe 16, 143–145. doi:, PMID:

    Not in our library10.1016/j.chom.2014.07.011 (opens in a new tab)

22. 22.

    Camilleri M. Oduyebo I. Halawi H. (2016 ). Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions. American journal of physiology-gastrointestinal and liver. Physiology 311, G777–G784

    Not in our library10.1152/ajpgi.00242.2016 (opens in a new tab)

23. 23.

    Canani R. B. Di Costanzo M. Leone L. Pedata M. Meli R. Calignano A. (2011 ). Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J. Gastroenterol. 17, 1519–1528. doi:, PMID:

    Not in our library10.3748/wjg.v17.i12.1519 (opens in a new tab)

24. 24.

    Catalkaya G. Venema K. Lucini L. Rocchetti G. Delmas D. Daglia M.. (2020 ). Interaction of dietary polyphenols and gut microbiota: microbial metabolism of polyphenols, influence on the gut microbiota, and implications on host health. Food Front. 1, 109–133

    Not in our library10.1002/fft2.25 (opens in a new tab)

25. 25.
    Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health · 2018

    No notice
26. 26.

    Chang P. V. Hao L. Offermanns S. Medzhitov R. (2014 ). The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. 111, 2247–2252. doi:, PMID:

    Not in our library10.1073/pnas.1322269111 (opens in a new tab)

27. 27.

    Chassard C. Delmas E. Robert C. Lawson P. A. Bernalier-Donadille A. (2012 ). Ruminococcus champanellensis sp. nov., a cellulose-degrading bacterium from human gut microbiota. Int. J. Syst. Evol. Microbiol. 62, 138–143

    Not in our library10.1099/ijs.0.027375-0 (opens in a new tab)

28. 28.
    Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease · 2019

    No notice
29. 29.

    Chen D. Jin D. Huang S. Wu J. Xu M. Liu T.. (2020 ). Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 469, 456–467. doi:, PMID:

    Not in our library10.1016/j.canlet.2019.11.019 (opens in a new tab)

30. 30.

    Chen G. Ran X. Li B. Li Y. He D. Huang B.. (2018 ). Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine 30, 317–325. doi:, PMID:

    Not in our library10.1016/j.ebiom.2018.03.030 (opens in a new tab)

31. 31.

    Chen W. Zhang S. Wu J. Ye T. Wang S. Wang P.. (2020 ). Butyrate-producing bacteria and the gut-heart axis in atherosclerosis. Clin. Chim. Acta 507, 236–241. doi:, PMID:

    Not in our library10.1016/j.cca.2020.04.037 (opens in a new tab)

32. 32.
    The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy · 2019

    Corrected
33. 33.
    Modulation of the human gut microbiota by dietary fibres occurs at the species level · 2016

    No notice
34. 34.

    Compare D. Coccoli P. Rocco A. Nardone O. M. De Maria S. Cartenì M.. (2012 ). Gut–liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 22, 471–476

    Not in our library10.1016/j.numecd.2012.02.007 (opens in a new tab)

35. 35.

    Cresci G. A. Glueck B. McMullen M. R. Xin W. Allende D. Nagy L. E. (2017 ). Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. J. Gastroenterol. Hepatol. 32, 1587–1597. doi:, PMID:

    Not in our library10.1111/jgh.13731 (opens in a new tab)

36. 36.

    Cuff M. A. Lambert D. W. Shirazi-Beechey S. P. (2002 ). Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. J. Physiol. 539, 361–371. doi:, PMID:

    Not in our library10.1113/jphysiol.2001.014241 (opens in a new tab)

37. 37.

    Dalile B. Van Oudenhove L. Vervliet B. Verbeke K. (2019 ). The role of short-chain fatty acids in microbiota–gut–brain communication. Nat. Rev. Gastroenterol. Hepatol. 16, 461–478. doi:, PMID:

    Not in our library10.1038/s41575-019-0157-3 (opens in a new tab)

38. 38.

    Damen B. Verspreet J. Pollet A. Broekaert W. F. Delcour J. A. CMJMN C.. (2011 ). Prebiotic effects and intestinal fermentation of cereal arabinoxylans and arabinoxylan oligosaccharides in rats depend strongly on their structural properties and joint presence. Mol. Nutr. Food Res. 55, 1862–1874

    Not in our library10.1002/mnfr.201100377 (opens in a new tab)

39. 39.

    Dang A. T. Marsland B. J. (2019 ). Microbes, metabolites, and the gut–lung axis. Mucosal Immunol. 12, 843–850. doi:, PMID:

    Not in our library10.1038/s41385-019-0160-6 (opens in a new tab)

40. 40.

    Das V. Kalita J. Pal M. (2017 ). Predictive and prognostic biomarkers in colorectal cancer: a systematic review of recent advances and challenges. Biomed. Pharmacother. 87, 8–19. doi:, PMID:

    Not in our library10.1016/j.biopha.2016.12.064 (opens in a new tab)

Cited by papers we hold 2

• Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease · 2023
  No notice
• Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota · 2023
  No notice

Questions about this paper

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.